Skip to content

mc-resource

February 14, 2022

MCTC Regulatory Barriers Survey Report

Follow up survey results to the MCTC Maturity Survey conducted in early 2021.  In Fall 2021, TransCelerate member companies were asked follow-up questions regarding the specific “regulatory, legal, and privacy barriers” that they had previously identified as roadblocks in implementing modern solutions in clinical trials, so that TransCelerate can better understand and discuss these challenges with regulators and other stakeholders.

Explore

December 9, 2021

Transforming Information Flow in Clinical Development: Get Value Today While Driving Toward Tomorrow

Learn how breaking the document paradigm will enable connectivity across the clinical development process. Topics covered will include: Future vision of the Harmonization Program of initiatives; Progress across the protocol digitization landscape; and Use case walkthrough: How the Schedule of Activities can unlock information flow across many processes. Learn about practical steps you can take to advance towards the future state, particularly through the Clinical Template Suite.

Explore

November 29, 2021

TransCelerate Town Hall: Nov. 16, 2021

On November 16, Board Members Dietmar Berger (Sanofi), Martin Lange (Novo Nordisk), and Rob Metcalf (Eli Lilly) joined TransCelerate COO Janice Chang for a one-hour session focused on the state of our collaboration and insights into the future of TransCelerate. Moderated by TransCelerate VP of Communications and Engagement, Jennifer Burgess, the panel discussed the importance of learning from the COVID-19 pandemic and taking those learnings into everything we do. The panel also highlighted recent successes from across the TransCelerate organization and provided an optimistic outlook for the future of clinical research and the importance of trusted collaboration to get to the desired future outcomes.

Explore